Applied Medical

appliedmedical.com

As a new generation medical device company, Applied Medical is focused on meeting three fundamental healthcare needs: enhanced clinical outcomes, cost containment and unrestricted choice. Our vertically integrated programs in design, development, manufacturing, and distribution enable us to consistently meet these objectives. Our state-of-the-art manufacturing plants are located in Southern California with distribution centers in Atlanta, New York, Europe, and Australia.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

TRILINK BIOTECHNOLOGIES AND IMPERIAL COLLEGE LONDON ANNOUNCE COLLABORATION TO PRODUCE SARNA FOR COVID-19 VACCINE DEVELOPMENT

Maravai LifeSciences | April 27, 2020

news image

TriLink BioTechnologies®, a Maravai LifeSciences company and a leader in the production of nucleic acids for research, diagnostics and therapeutics applications, and Imperial College London, a public research university located in the United Kingdom, announced today that they have entered into a partnership in which TriLink will manufacture self-amplifying RNA (saRNA) for COVID-19 vaccine development. The vaccine development program is led by Professor Robin Shattock, Head of Mucosal Infecti...

Read More

GINKGO BIOWORKS ANNOUNCES PARTNERSHIP WITH TOTIENT TO IDENTIFY NEUTRALIZING ANTIBODIES AGAINST COVID-19

Ginkgo Bioworks | September 11, 2020

news image

Today, Ginkgo Bioworks announced a partnership with Totient, an AI-driven drug discovery company emerging from stealth, to rapidly identify neutralizing antibodies against COVID-19. Through this partnership, Totient will leverage Ginkgo's bioengineering platform to express and screen thousands of antibody candidates with the aim of identifying broadly neutralizing therapeutic antibodies against COVID-19 for further development. Totient leverages tertiary lymphoid structures (TLSs) to identif...

Read More

Research

LUNAPHORE AND INDICA LABS ANNOUNCE PARTNERSHIP TO PROVIDE COMPLETE TECHNOLOGY SOLUTION FOR SPATIAL BIOLOGY AND IMAGE ANALYSIS

Indica Labs | May 13, 2022

news image

Lunaphore, a Swiss life sciences company developing technology to enable spatial biology in every laboratory, and Indica Labs, a leading provider of computational pathology software and services, today announced a partnership to co-market an end-to-end solution that combines Lunaphore's flagship COMET™ spatial biology platform and Indica's HALO® and HALO AI™ digital pathology image analysis software. Lunaphore's COMET™ platform provides superior m...

Read More

Industrial Impact, Medical

HITGEN ANNOUNCES RESEARCH AGREEMENT WITH NITRASE THERAPEUTICS FOCUSED ON DNA-ENCODED LIBRARY BASED DRUG DISCOVERY

HitGen Inc. | December 12, 2022

news image

Shanghai Stock Exchange listed company HitGen Inc. announced that it has entered into a research agreement with Nitrase Therapeutics, Inc. a biopharmaceutical company deploying its NITROME platform to build a pipeline of therapies targeting nitrases, which is a new class of enzymes discovered by Nitrase that are involved in a broad variety of diseases. Nitrases have been implicated in numerous devastating diseases, including Parkinson's, cancer, respiratory diseases, fibrosis ...

Read More
news image

TRILINK BIOTECHNOLOGIES AND IMPERIAL COLLEGE LONDON ANNOUNCE COLLABORATION TO PRODUCE SARNA FOR COVID-19 VACCINE DEVELOPMENT

Maravai LifeSciences | April 27, 2020

TriLink BioTechnologies®, a Maravai LifeSciences company and a leader in the production of nucleic acids for research, diagnostics and therapeutics applications, and Imperial College London, a public research university located in the United Kingdom, announced today that they have entered into a partnership in which TriLink will manufacture self-amplifying RNA (saRNA) for COVID-19 vaccine development. The vaccine development program is led by Professor Robin Shattock, Head of Mucosal Infecti...

Read More
news image

GINKGO BIOWORKS ANNOUNCES PARTNERSHIP WITH TOTIENT TO IDENTIFY NEUTRALIZING ANTIBODIES AGAINST COVID-19

Ginkgo Bioworks | September 11, 2020

Today, Ginkgo Bioworks announced a partnership with Totient, an AI-driven drug discovery company emerging from stealth, to rapidly identify neutralizing antibodies against COVID-19. Through this partnership, Totient will leverage Ginkgo's bioengineering platform to express and screen thousands of antibody candidates with the aim of identifying broadly neutralizing therapeutic antibodies against COVID-19 for further development. Totient leverages tertiary lymphoid structures (TLSs) to identif...

Read More
news image

Research

LUNAPHORE AND INDICA LABS ANNOUNCE PARTNERSHIP TO PROVIDE COMPLETE TECHNOLOGY SOLUTION FOR SPATIAL BIOLOGY AND IMAGE ANALYSIS

Indica Labs | May 13, 2022

Lunaphore, a Swiss life sciences company developing technology to enable spatial biology in every laboratory, and Indica Labs, a leading provider of computational pathology software and services, today announced a partnership to co-market an end-to-end solution that combines Lunaphore's flagship COMET™ spatial biology platform and Indica's HALO® and HALO AI™ digital pathology image analysis software. Lunaphore's COMET™ platform provides superior m...

Read More
news image

Industrial Impact, Medical

HITGEN ANNOUNCES RESEARCH AGREEMENT WITH NITRASE THERAPEUTICS FOCUSED ON DNA-ENCODED LIBRARY BASED DRUG DISCOVERY

HitGen Inc. | December 12, 2022

Shanghai Stock Exchange listed company HitGen Inc. announced that it has entered into a research agreement with Nitrase Therapeutics, Inc. a biopharmaceutical company deploying its NITROME platform to build a pipeline of therapies targeting nitrases, which is a new class of enzymes discovered by Nitrase that are involved in a broad variety of diseases. Nitrases have been implicated in numerous devastating diseases, including Parkinson's, cancer, respiratory diseases, fibrosis ...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us